Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine.

Authors' A Maryland B Microbiolo Center, Lo Orleans, Lo

[1]  P. Sinha,et al.  Myeloid-Derived Suppressor Cells Down-Regulate L-Selectin Expression on CD4+ and CD8+ T Cells1 , 2009, The Journal of Immunology.

[2]  M. Atkins,et al.  Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. , 2009, Cancer research.

[3]  A. Rubartelli,et al.  The thiol redox state of lymphoid organs is modified by immunization: Role of different immune cell populations , 2008, European journal of immunology.

[4]  Yuzhuo Wang,et al.  The xc− cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance , 2008, British Journal of Cancer.

[5]  D. Gabrilovich,et al.  Tumor escape mechanism governed by myeloid-derived suppressor cells. , 2008, Cancer research.

[6]  P. Rodriguez,et al.  Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives , 2008, Immunological reviews.

[7]  V. Bronte,et al.  Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells , 2008, Immunological reviews.

[8]  M. Fishman,et al.  Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells. , 2007, Cancer research.

[9]  Jonathan Pevsner,et al.  HIF-dependent antitumorigenic effect of antioxidants in vivo. , 2007, Cancer cell.

[10]  S. Albelda,et al.  Cross-Talk between Myeloid-Derived Suppressor Cells and Macrophages Subverts Tumor Immunity toward a Type 2 Response1 , 2007, The Journal of Immunology.

[11]  K. Gupta,et al.  Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer , 2007, Nature Medicine.

[12]  L. Mariani,et al.  Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  N. Okamura,et al.  Expression and function of cystine/glutamate transporter in neutrophils , 2007, Journal of leukocyte biology.

[14]  V. La Bella,et al.  Expression and Developmental Regulation of the Cystine/Glutamate Exchanger (xc−) in the Rat , 2007, Neurochemical Research.

[15]  C. Knudson,et al.  The Scaffolding Protein CG-NAP/AKAP450 Is a Critical Integrating Component of the LFA-1-Induced Signaling Complex in Migratory T Cells1 , 2005, The Journal of Immunology.

[16]  P. Chumakov,et al.  The antioxidant function of the p53 tumor suppressor , 2005, Nature Medicine.

[17]  L. Kaiser,et al.  Gemcitabine Selectively Eliminates Splenic Gr-1+/CD11b+ Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune Activity , 2005, Clinical Cancer Research.

[18]  S. Signoretti,et al.  Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. , 2005, Cancer research.

[19]  P. Sinha,et al.  Reduction of Myeloid-Derived Suppressor Cells and Induction of M1 Macrophages Facilitate the Rejection of Established Metastatic Disease1 , 2005, The Journal of Immunology.

[20]  B. Fingleton,et al.  Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. , 2004, Cancer cell.

[21]  K. Namekata,et al.  Murine cystathionine gamma-lyase: complete cDNA and genomic sequences, promoter activity, tissue distribution and developmental expression. , 2004, The Biochemical journal.

[22]  D. Gabrilovich,et al.  Antigen-Specific Inhibition of CD8+ T Cell Response by Immature Myeloid Cells in Cancer Is Mediated by Reactive Oxygen Species1 , 2004, The Journal of Immunology.

[23]  J. Manson,et al.  A prospective study of plasma total cysteine and risk of breast cancer. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[24]  O. Finn,et al.  Cancer vaccines: between the idea and the reality , 2003, Nature Reviews Immunology.

[25]  V. Bronte,et al.  L-arginine metabolism in myeloid cells controls T-lymphocyte functions. , 2003, Trends in immunology.

[26]  S. Egawa,et al.  A novel bulk-culture method for generating mature dendritic cells from mouse bone marrow cells. , 2002, Journal of immunological methods.

[27]  C. Thompson,et al.  Antigen-presenting cells control T cell proliferation by regulating amino acid availability , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[28]  G. Filomeni,et al.  Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  N. Bruchovsky,et al.  Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the xc− cystine transporter: a new action for an old drug , 2001, Leukemia.

[30]  T. Murphy,et al.  xCt cystine transporter expression in HEK293 cells: pharmacology and localization. , 2001, Biochemical and biophysical research communications.

[31]  D. Gabrilovich,et al.  Human squamous cell carcinomas of the head and neck chemoattract immune suppressive CD34(+) progenitor cells. , 2001, Human immunology.

[32]  Nicholas R. English,et al.  Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer1 , 2001, The Journal of Immunology.

[33]  Elias S. J. Arnér,et al.  Physiological functions of thioredoxin and thioredoxin reductase. , 2000, European journal of biochemistry.

[34]  Shu-Hsia Chen,et al.  Gr-1+ Myeloid Cells Derived from Tumor-Bearing Mice Inhibit Primary T Cell Activation Induced Through CD3/CD28 Costimulation1 , 2000, The Journal of Immunology.

[35]  S. Rosenberg,et al.  Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells. , 1998, Journal of immunology.

[36]  P. Ueland,et al.  Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. , 1992, Analytical biochemistry.

[37]  W. Dröge,et al.  Low membrane transport activity for cystine in resting and mitogenically stimulated human lymphocyte preparations and human T cell clones. , 1991, European journal of biochemistry.

[38]  M. Smyth.  Glutathione modulates activation-dependent proliferation of human peripheral blood lymphocyte populations without regulating their activated function. , 1991, Journal of immunology.

[39]  W. Dröge,et al.  Macrophages regulate intracellular glutathione levels of lymphocytes. Evidence for an immunoregulatory role of cysteine. , 1990, Cellular immunology.

[40]  T. Ishii,et al.  Neutral amino acid transport in mouse peritoneal macrophages. , 1987, The Journal of biological chemistry.

[41]  S. Bannai.  Transport of cystine and cysteine in mammalian cells. , 1984, Biochimica et biophysica acta.

[42]  H. Eagle,et al.  The synthesis of homocystine, cystathionine, and cystine by cultured diploid and heteroploid human cells. , 1966, Proceedings of the National Academy of Sciences of the United States of America.

[43]  A. Sato,et al.  Phase III trial of upfront debulking surgery versus neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0602. , 2008, Japanese journal of clinical oncology.

[44]  Y. Yamaoka,et al.  Possible availability of N-acetylcysteine as an adjunct to cytokine therapy for hepatocellular carcinoma. , 1998, Clinical immunology and immunopathology.

[45]  岩田 哲史.  Thiol-mediated redox regulation of lymphocyte proliferation : possible involvement of adult T cell leukemia-derived factor and glutathione in transferrin receptor expression , 1995 .